Who owns the APOPTOSIS NUTRACEUTICALS trademark?

The APOPTOSIS NUTRACEUTICALS trademark is owned by Ershadi, Shohreh, Sadigh.

What class is the APOPTOSIS NUTRACEUTICALS trademark registered in?

The APOPTOSIS NUTRACEUTICALS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for APOPTOSIS NUTRACEUTICALS?

The USPTO serial number for APOPTOSIS NUTRACEUTICALS is 98365888.

What is the registration number for APOPTOSIS NUTRACEUTICALS?

APOPTOSIS NUTRACEUTICALS is registered under USPTO registration number 7592093.

APO

USPTO Trademark Record

REGISTERED

APOPTOSIS NUTRACEUTICALS

SN 98365888·Reg 7592093·Filed Jan 19, 2024

Owner Ershadi, Shohreh, Sadigh

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

APOPTOSIS NUTRACEUTICALS (Serial No. 98365888), Registration No. 7592093, is a registered US trademark filed on Jan 19, 2024 by Ershadi, Shohreh, Sadigh. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: December 03, 2030

Mark Intelligence

APOPTOSIS NUTRACEUTICALS (Reg. #7592093) is a registered US trademark that has been protecting its owner, Ershadi, Shohreh, Sadigh, since 2024. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs....

FILED

Jan 19, 2024

SERIAL

98365888

REG#

7592093

REGISTERED

Dec 03, 2024

Owner

Applicant

Ershadi, Shohreh, Sadigh

Entity

Individual

Address

#303, 1000 Granville Ave, Los Angeles, CA, 90049

Country

Attorney

Law firm

Ershadi, Shohreh, Sadigh

Docket

98365888

Address

#303, 1000 Granville Ave, Los Angeles, CA 90049, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateJan 19, 2024

Serial Number98365888

Registration No.7592093

Registration DateDec 03, 2024

Status DateDec 03, 2024

Mark TypeStandard characters

Attorney Docket98365888

Status DescriptionLive and registered

Filing Signals

FILED

2024

YEARS AGO

CLASSES

MADRID FILINGS

—

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Jan 16, 2024

First use in commerce: Jan 16, 2024

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

23 events

REGISTERED-SUPPLEMENTAL REGISTER

Dec 03, 2024

REGISTERED-SUPPLEMENTAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Dec 03, 2024

NOTICE OF REGISTRATION CONFIRMATION EMAILED

EXAMINERS AMENDMENT -WRITTEN

Oct 16, 2024

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Oct 16, 2024

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Oct 16, 2024

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Oct 16, 2024

EXAMINER'S AMENDMENT ENTERED

USE AMENDMENT ACCEPTED

Oct 16, 2024

USE AMENDMENT ACCEPTED

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

Oct 16, 2024

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

TEAS AMENDMENT OF USE RECEIVED

Oct 14, 2024

TEAS AMENDMENT OF USE RECEIVED

USE AMENDMENT FILED

Oct 14, 2024

USE AMENDMENT FILED

AMENDMENT TO USE PROCESSING COMPLETE

Oct 14, 2024

AMENDMENT TO USE PROCESSING COMPLETE

FINAL REFUSAL WRITTEN

Oct 09, 2024

FINAL REFUSAL WRITTEN

FINAL REFUSAL E-MAILED

Oct 09, 2024

FINAL REFUSAL E-MAILED

NOTIFICATION OF FINAL REFUSAL EMAILED

Oct 09, 2024

NOTIFICATION OF FINAL REFUSAL EMAILED

TEAS/EMAIL CORRESPONDENCE ENTERED

Sep 12, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Sep 11, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 11, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION WRITTEN

Aug 16, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Aug 16, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Aug 16, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Aug 15, 2024

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 25, 2024

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jan 19, 2024

NEW APPLICATION ENTERED

APOPTOSIS NUTRACEUTICALS

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Resources

Company